Skip to main content

NICE

Volume 450: debated on Wednesday 25 October 2006

To ask the Secretary of State for Health if she will change the remit and scope of the National Institute for Health and Clinical Excellence investigations to allow it to take into account the wider benefits to families of patients and society that can arise from drug treatments. (94591)

[holding answer 18 October 2006]: The National Institute for Health and Clinical Excellence (NICE) already takes factors such as wider benefits to patients’ families and society into account where it is appropriate to do so. For example, NICE’s economic modelling on its work for the appraisal of drugs for Alzheimer’s disease has included an assessment of the impact of benefits accruing to carers.